The Global scenario of the Microbiology Testing Market, this market is one of the fastest growing market and expected to continue its growth near future. The total market for Microbiology testing was US$ 2706.1 million in 2016 and expected to reach US$ 5409.1 million by 2023. While considering the segments, Chemicals & Reagents was holding largest market share that was about 42.1% in 2016.
Microbiology Testing Market – SWOT Analysis
- Increasing prevalence of infectious diseases
- Increasing adoption of new methods and techniques
- Increasing use of advanced products
- Rapidly changing disease pattern
- High cost of some testing and products
- Emerging markets
- Increasing funding for research
- Traditional techniques and lab practices
- Slow adaption rate in middle and low income countries
Microbiology Testing Market – Major Players
Some of the key players in this market are: Alere (US), BD (US), Beckman Coulter, Inc. (US), Biomérieux SA (France), Cepheid (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US)
Microbiology Testing Market – Highlights
Microbiology testing has emerged as one of the rapidly changing segment of healthcare over the past few years. Microbiology testing deals with the study of microbial germs and their clinical applications for the improvement of health. Increasing prevalence of various infectious diseases are driving the growth for Global Microbiology Testing Market.
According to a recent study published by the Market Research Future analysts, the global microbiology testing market is growing at a double digit growth rate; mainly due to factors such as technological advancements, rising cases of infectious diseases, surveillance programs for disease control, and rising stringency of standards. On the other hand, erroneous results produced during the testing, and heavy costs of the tests and instruments have created some obstacles in the growth of this market in all parts of the world.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/697
Microbiology Testing Market – Segmentation
Global Microbiology testing Market has been segmented on the basis of type which comprise Instruments, Chemicals & Reagents, Consumables & Accessories, and others. On the basis of application, it is segmented into, Gastrointestinal Infections, Respiratory Infections, Urinary tract Infections, Sexually Transmitted Infections, Others. On the basis of end user, it is segmented into, Hospital based laboratory, Independent laboratory, and Academics & Research Institutes.
Microbiology Testing Market – Regional Analysis
Considering the global scenario of the microbiology testing market, North America is largest market for Microbiology testing. In 2016, Europe was holding major market share slightly lesser than North America in global microbiology testing market. Countries like Germany, France and UK are holding major stake in this market. The Asia-Pacific (APAC) region is witnessing faster growth of microbiology testing market. While Middle East and Africa shown limited growth in microbiology testing market and expected to grow with a steady pace during the forecast period.
Global Microbiology Testing Market – Competitive Analysis
There are large number of companies involved in the development of the products, instruments, and test kits for the microbiology testing which are now being used in majority part of the developed countries. Global market for microbiology testing is majorly dominated by Biomérieux SA with more than 40% of market share in 2016.
Major companies are adopting a specific strategy to enter and create unique space in this market. The different strategies includes, product launch, agreement and collaboration, partnership and expansion, joint venture and strategic alliance etc. All major players are focusing on new product development to provide new and innovative solutions to the market.
Biomérieux SA offers a comprehensive range diagnostic solutions which include Microbiology lab instruments, reagents and software. The products of the company is mainly used for diagnosing infectious diseases. In 2016, BioMérieux announced the acquisition of Hyglos. With this acquisition, the company plans to strengthen its position in the market.
Some of the major developments in this segment came from the Roche Diagnostics. In April 2017, the company received FDA clearance for the CINtec Histology test. This test is the only clinically validated p16 biomarker test. The CINtec Histology test will help physicians make informed decisions as to the best course of care for patients with high-grade pre-cancerous cervical disease. Back in 2015, Roche acquired GeneWEAVE to strengthen offerings in microbiology diagnostics.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/697
Some of Major Table of Content for “Global Microbiology Testing Market Research Report – Forecast to 2023”
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312